Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 01/02/2018.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Research Papers:
A uniform thymic malignant lymphoma model established with C57BL/6 p53 gene deficient mice
Changfa Fan1,*, Jianjun Lyu2,*, Susu Liu1,*, Xi Wu1, Qianqian Li2, Shuya Zhou1, Yanwei Yang2, Guitao Huo2, Qin Zuo1, Qingfen Zhu3, Ming Guo3, Simei Ren4, Yanan Guo5, Sanlong Wang2, Baowen Li1, Xue Wang2, Yuelei Shen5 and Youchun Wang1
1Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Tiantan Xili, Beijing 100050, China
2National Center for Safety Evaluation of Drugs, Institute for Food and Drug Safety Evaluation, National Institutes for Food and Drug Control, Beijing Economic-Technological Development Area, Beijing 100176, China
3Shandong Institute for Food and Drug Control, High-Tech Zone, Jinan 250101, China
4Department of Hematology, National Center for Clinical Laboratories and Beijing Hospital, Beijing 100730, China
5Beijing Biocytogen Co. LTD, Economic-Technological Development Area, Beijing 101111, China
*These authors contributed equally to this work
Correspondence to:
Youchun Wang, email: [email protected]
Keywords: p53 deficient mouse; lymphoma model; MNU induction; C57BL/6 genetic background; T cell lineage
Received: November 01, 2016 Accepted: December 03, 2017 Published: January 02, 2018
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24108